UAE ministry recalls aspirin brand from shelves

All packets of the product must be returned to the supplier

  
An aerial view shows an administration building of the German Bayer AG chemical company in Leverkusen wrapped as giant "Aspirin" box March 6. Bayer celebrates the 100th anniversary of the company's famous pain-killer.

An aerial view shows an administration building of the German Bayer AG chemical company in Leverkusen wrapped as giant "Aspirin" box March 6. Bayer celebrates the 100th anniversary of the company's famous pain-killer.

REUTERS/Reuters Photographer

The Ministry of Health and Community Prevention issued a circular recalling the drug Jusprin(81mg) from all pharmacies and hospitals in the UAE.

The drug, made by Gulf Pharmaceutical Industries, Julphar, did not meet the health standards and guidelines of the Gulf Cooperation Council for pharmaceuticals.

All packetsof the product must be returned to the supplier and taken off the shelves of pharmacies and medical establishments in the public and private sector.

Medical practitioners must refrain from prescribing or using the aforementioned product.

If you have used the drug andfelt adverse side effects, please contact the ministry at 04 2301448 or at their email pv@moh.gov.ae.

Jusprinis used to reducefever, mild to moderatepainfrom aheadache, menstrual periods,cold, toothache, or muscle ache.

It is also used to relieve pain associated with inflammation of joints caused by rheumatoidarthritisor long-lasting degeneration of joints caused byosteoarthritisas well asreduce the risk of a heart attack orstrokein patients who have a history of heart disease or stroke associated symptoms.

Copyright © 2019 Khaleej Times. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Commercial